MARKET

ADMP

ADMP

Adamis Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.040
-0.010
-0.95%
After Hours: 1.040 0 0.00% 19:56 09/24 EDT
OPEN
1.050
PREV CLOSE
1.050
HIGH
1.060
LOW
1.020
VOLUME
1.40M
TURNOVER
--
52 WEEK HIGH
2.340
52 WEEK LOW
0.3755
MARKET CAP
154.84M
P/E (TTM)
-1.6707
1D
5D
1M
3M
1Y
5Y
Adamis (ADMP) Begins Dosing in COVID Oral Antiviral Study
Zacks.com · 09/03 16:12
Adamis Stock Jumps As Its Oral COVID-19 Drug Trial Starts Dosing
Benzinga · 09/02 14:56
Adamis Pharmaceuticals Doses First Patients in Phase 2/3 Clinical Trial for Tempol in the Treatment of COVID-19
Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) today announced the initiation of patient dosing in the Phase 2/3 clinical trial for Tempol, an oral antiviral product candidate, in adult patients with confirmed COVID-19 infection. In preclinical studies,...
GlobeNewswire · 09/02 11:37
Adamis Pharmaceuticals Begins Dosing Patients in Phase 2/3 Trial of Tempol to Treat COVID-19; Shares Rise Near 4%
MT Newswires · 09/02 09:41
BRIEF-Adamis Announces Appointment Of David Benedicto As Chief Financial Officer And Other Events
reuters.com · 08/24 20:18
Immunology Journal Publishes Data For Adamis' COVID-19 Candidate
Benzinga · 08/24 17:14
Adamis Pharmaceuticals Names New CFO
MT Newswires · 08/24 16:58
BRIEF-Adamis Announces Publication On Tempol In COVID-19 Patient's Cells
reuters.com · 08/24 12:20
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ADMP. Analyze the recent business situations of Adamis Pharma through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ADMP stock price target is 1.000 with a high estimate of 1.000 and a low estimate of 1.000.
EPS
Institutional Holdings
Institutions: 81
Institutional Holdings: 18.69M
% Owned: 12.56%
Shares Outstanding: 148.89M
TypeInstitutionsShares
Increased
19
2.42M
New
10
3.17M
Decreased
3
560.09K
Sold Out
11
1.42M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.45%
Pharmaceuticals & Medical Research
-1.02%
Key Executives
Chairman/Independent Director
Richard Williams
Chief Executive Officer/President/Director
Dennis Carlo
Chief Financial Officer/Chief Accounting Officer
David Benedicto
Senior Vice President/Director
David Marguglio
Vice President - Operations
Karen Daniels
Other
Ronald Moss
Independent Director
Howard Birndorf
Independent Director
Roshawn Blunt
No Data
About ADMP
Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company. It is focused on developing and commercializing products in therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease. Its product includes, SYMJEP (epinephrine) Injection 0.3 miligram for treatment of acute allergic reactions, including anaphylaxis, for patients weighing 66 pounds or more, and SYMJEPI (epinephrine) Injection 0.15 miligram for the treatment of anaphylaxis for patients weighing 33-65 pounds. Its other product candidates includes ZIMHI, a high dose 5 miligram naloxone injection, based on the approved Symject injection device for the treatment of opioid overdose, and APC-400 (tempol) for the treatment of respiratory diseases including asthma, respiratory syncytial virus, influenza and COVID-19, APC-1000 a hydrofluoroalkane (HFA) inhalable oral steroid for the treatment of asthma and COPD APC-4000 Fluticasone, a dry powder inhalation for the treatment of asthma.

Webull offers kinds of Adamis Pharmaceuticals Corp stock information, including NASDAQ:ADMP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADMP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ADMP stock methods without spending real money on the virtual paper trading platform.